Recruiting A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia NCT05849662 Conditions Bone Marrow Diseases, CBL Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more Locations Phoenix Children's Hospital — Phoenix, Arizona, United States Children's Hospital Los Angeles — Los Angeles, California, United States University of California San Francisco — San Francisco, California, United States Children's Hospital of Colorado — Denver, Colorado, United States View all 19 locations View more locations Show fewer locations Loading locations... View Trial Details
